VS-01 on top of SOC
Phase 2Terminated 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Acute-On-Chronic Liver Failure
Conditions
Acute-On-Chronic Liver Failure, Ascites
Trial Timeline
Jul 2, 2023 → Oct 15, 2025
NCT ID
NCT05900050About VS-01 on top of SOC
VS-01 on top of SOC is a phase 2 stage product being developed by Genfit for Acute-On-Chronic Liver Failure. The current trial status is terminated. This product is registered under clinical trial identifier NCT05900050. Target conditions include Acute-On-Chronic Liver Failure, Ascites.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05900050 | Phase 2 | Terminated |
Competing Products
2 competing products in Acute-On-Chronic Liver Failure
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| SMT + PE-A 5% | Grifols | Phase 3 | 74 |
| Single Dose G1090N + Multiple dosing of G1090N | Genfit | Phase 1 | 25 |